Brain chemistry imbalance revealed in violent offenders with antisocial personality disorder

In a new study shedding light on the neurological underpinnings of antisocial behavior, scientists have made a pivotal discovery regarding the brain chemistry of violent offenders diagnosed with Antisocial Personality Disorder, both with and without psychopathy. Their findings have been published in the journal Molecular Psychiatry.

The research reveals a significant imbalance in the striatum — a key brain area involved in decision-making — between two crucial neurotransmitters, glutamate and gamma-aminobutyric acid (GABA). This imbalance, identified through advanced imaging techniques, offers new insights into the neural mechanisms contributing to antisocial and violent behaviors, potentially paving the way for innovative treatments.

Conduct Disorder (CD) is a psychiatric condition diagnosed in childhood or adolescence characterized by a persistent pattern of behavior that violates societal norms, rights of others, and is often marked by aggression towards people or animals, destruction of property, deceitfulness, theft, or serious violations of rules.

Antisocial Personality Disorder (ASPD) is a condition diagnosed in adulthood that entails a long-term pattern of manipulating, exploiting, or violating the rights of others. This disorder is often seen as the adult continuation of the behaviors seen in CD, but with more pronounced features of disregard for societal norms and an inability to form stable personal relationships.

Psychopathy, often considered a more severe form of ASPD, includes traits of lack of empathy, superficial charm, high levels of manipulativeness, and a lack of remorse. While ASPD focuses on behavioral patterns, psychopathy includes these behavioral patterns as well as specific personality and affective traits.

Free daily newsletter

Previous research has identified a subset of individuals diagnosed with CD in childhood and later with ASPD in adulthood. This group is responsible for a disproportionate amount of violent crime and is notoriously difficult to treat, partly due to an early onset of offending and a dense pattern of antisocial behavior.

However, while deficits in empathic processing and decision-making have been associated with such life-course persistent antisocial behavior, particularly among those with additional psychopathic traits, the specific neural mechanisms, particularly in terms of decision-making processes, remained poorly understood.

To delve into these mechanisms, the researchers recruited a sample of 51 men, divided into two groups: 30 offenders with ASPD, further subdivided based on the presence (14) or absence (16) of psychopathy, and 21 healthy non-offenders. The inclusion criteria for offenders were convictions for violent crimes and a diagnosis of ASPD based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria. Non-offenders were recruited from the general population.

Upon enrollment, participants underwent a comprehensive diagnostic assessment, including the Structured Clinical Interview for DSM-5 Disorders (SCID-5-RV) and the Psychopathy Checklist-Revised (PCL-R), alongside authorization for access to their criminal records. This assessment ensured accurate classification of participants based on their diagnostic status and psychopathy levels.

The core of the study’s methodology revolved around proton magnetic resonance spectroscopy (1H-MRS), performed using a 3 Tesla General Electric MR750 Discovery scanner. This technique allowed the researchers to quantify the balance between two critical neurotransmitters in the striatum: glutamate, which is excitatory, and GABA, which is inhibitory. This balance is crucial for the proper functioning of the striatum.

The researchers discovered that violent offenders with ASPD exhibited a significant disruption in the glutamate to GABA ratio in the striatum when compared to non-offending individuals. This suggests that an abnormal balance of excitatory and inhibitory transmission in the striatum, which could be a contributing factor to the decision-making deficits observed in antisocial and violent behaviors.

Interestingly, when comparing the subgroups of offenders with ASPD—with and without psychopathy—no significant difference in the striatal glutamate to GABA ratio was found. This suggests that the neurochemical imbalance in the excitatory and inhibitory transmission in the striatum is a shared feature of ASPD, irrespective of the presence of psychopathic traits.

Furthermore, the study did not find a significant correlation between the severity of psychopathic traits, as measured by the Psychopathy Checklist-Revised (PCL-R) scores, and the glutamate to GABA ratio within either the offender or non-offender groups. This lack of correlation further underscores the notion that the observed neurochemical imbalance is a general characteristic of ASPD, rather than being directly related to the degree of psychopathy.

While the study represents a significant advance in our understanding of the neural correlates of antisocial behavior, the authors acknowledge several limitations. The sample size, though adequate for detecting group differences, was relatively small, which might limit the detection of subtler differences within the ASPD group.

Additionally, the influence of external factors, such as substance misuse, though accounted for, remains a concern for the generalizability of the findings. The researchers also highlight the cross-sectional nature of the study, which precludes causal inferences about the relationship between striatal neurotransmitter balance and antisocial behavior.

Looking forward, the study opens multiple avenues for further research. Future studies could explore the functional consequences of striatal neurotransmitter imbalance on behavior, potentially integrating neuropsychological tasks to directly link neurochemical findings with decision-making processes. Additionally, investigating the possibility of targeting the identified imbalance with pharmacological interventions could offer new therapeutic strategies for addressing antisocial behavior.

The study, “Impaired striatal glutamate/GABA regulation in violent offenders with antisocial personality disorder and psychopathy,” was authored by John Tully, Andreia C. Pereira, Arjun Sethi, Julia Griem, Ben Cross, Steve CR Williams, Robert James Blair, Declan Murphy, and Nigel Blackwood.